In cancer, RBM15 has emerged as a significant factor influencing tumor growth, cell proliferation, and metastasis. Its activity affects multiple signaling pathways and gene networks, promoting disease ...
Scientists have unveiled a powerful new tool called PerturbFate that could change how researchers tackle diseases driven by ...
Immunotherapy has transformed cancer care, offering a way to harness the body’s own immune system to fight tumors. But even with these advances, many patients still don’t respond. One major barrier to ...
Kinases that shuttle cholesterol within tumor cells help fuel growth. Blocking these enzymes may starve cancer cells, ...
Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...
A new study suggests that Resmetirom may do more than treat fatty liver disease — it could also help stop liver cancer from ...
Lucknow: In a breakthrough that could reshape colorectal cancer treatment strategies, researchers at the Indian Institute of ...
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results